Breaking News Instant updates and real-time market news.

PTE

PolarityTE

$5.54

0.02 (0.36%)

07:10
07/08/19
07/08
07:10
07/08/19
07:10

PolarityTE initiated with a Buy at H.C. Wainwright

H.C. Wainwright analyst Swayampakula Ramakanth started PolarityTE with a Buy rating and $8 price target. The company's SkinTE has the potential to revolutionize the $40B wound care market, Ramakanth tells investors in a research note. Further, PolarityTE has made several leadership changes in the last three months that could "well change the face of the investment prospects," adds the analyst. He believes the company's technology platform could expand to many products.

  • 09

    Sep

PTE PolarityTE
$5.54

0.02 (0.36%)

04/08/19
OPCO
04/08/19
NO CHANGE
Target $30
OPCO
Outperform
Data from DLS meeting give 'major boost' to SkinTE outlook, says Oppenheimer
Oppenheimer analyst Kevin DeGeeter said data presented on April 5 at the Diabetic Limb Salvage meeting were "dramatically better than the 0-25% complete healing rate we would have expected" in diabetic foot ulcer patients, which he views as giving a "major boost" to the outlook for SkinTE in chronic wounds. DeGeeter maintains an Outperform rating on PolarityTE with a $30 price target.
04/08/19
CANT
04/08/19
NO CHANGE
CANT
Cantor reiterates Overweight rating on PolarityTE after recent presentations
Cantor Fitzgerald analyst Elemer Piros reiterated an Overweight rating and $65 price target on PolarityTE following recent presentations at the Diabetic Limb Salvage, or DLS, Conference, including PolarityTE showing a 12-week study evaluating the application of SkinTE on 11 unique diabetic foot ulcers that failed previous therapies in which ten of the eleven, or 91%, of the wounds were closed by 12 weeks, and remained closed upon inspection two weeks thereafter. Piros believes these results "demonstrate the ability of SkinTE to work in difficult situations, with a high success rate."
04/30/19
CANT
04/30/19
NO CHANGE
Target $65
CANT
Overweight
PolarityTE's SkinTE may address certain genetic diseases, says Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros says PolarityTE's presentation yesterday highlighted differentiated case studies in which SkinTE was an effective treatment in restoring the regenerative properties of skin. In one case study, SkinTE was applied to correct a previous failed split-thickness skin graft, Piros tells investors in a research note. Although early, preclinical work shows a potential for SkinTE to address certain genetic diseases, contends the analyst. He believes upcoming data presentations at the Symposium on Advanced Wound Care Conference on May 7-11 is an "important upcoming catalyst." Piros thinks PolarityTE "can revolutionize the field of regenerative medicine." He reiterates an Overweight rating on the shares with a $65 price target.
05/10/19
PIPR
05/10/19
NO CHANGE
Target $26
PIPR
Overweight
Piper cuts 2019 sales estimate for PolarityTE's SkinTE by 75% to $5M
Piper Jaffray analyst Tyler Van Buren says that while adoption of PolarityTE's SkinTE is improving with the number of patients treated up 47% quarter-over-quarter in Q1, sales of $297,000 were below expectations due to an increase in the proportion of lower cost chronic wounds. Following the results, the analyst reset his near-term launch expectations and decreased his 2019 annual SkinTE sales estimate to $5M from $20M. However, Van Buren's long-term sales estimates are still largely intact at over $300M. As such, he keeps an Overweight rating on PolarityTE shares.

TODAY'S FREE FLY STORIES

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
07/23/19
07/23
08:20
07/23/19
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$191.09

0.3 (0.16%)

08:20
07/23/19
07/23
08:20
07/23/19
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$81.62

0.97 (1.20%)

08:19
07/23/19
07/23
08:19
07/23/19
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$63.07

0.33 (0.53%)

08:19
07/23/19
07/23
08:19
07/23/19
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$207.21

4.59 (2.27%)

, INTC

Intel

$51.36

1.1 (2.19%)

08:19
07/23/19
07/23
08:19
07/23/19
08:19
Recommendations
Apple, Intel analyst commentary  »

Apple buying Intel modem…

AAPL

Apple

$207.21

4.59 (2.27%)

INTC

Intel

$51.36

1.1 (2.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

  • 03

    Aug

XLY

Consumer Discretionary Sector SPDR

$122.22

0.07 (0.06%)

08:19
07/23/19
07/23
08:19
07/23/19
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OPNT

Opiant Pharmaceuticals

$12.94

-0.06 (-0.46%)

, SNY

Sanofi

$42.19

0.25 (0.60%)

08:19
07/23/19
07/23
08:19
07/23/19
08:19
Hot Stocks
Opiant Pharmaceuticals, Sanofi sign agreement for manufacturing OPNT004 »

Opiant Pharmaceuticals…

OPNT

Opiant Pharmaceuticals

$12.94

-0.06 (-0.46%)

SNY

Sanofi

$42.19

0.25 (0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jul

  • 16

    Sep

  • 23

    Sep

  • 02

    Oct

XLB

S&P Select Materials SPDR

$58.28

-0.11 (-0.19%)

08:18
07/23/19
07/23
08:18
07/23/19
08:18
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAA

Under Armour

$26.64

-0.31 (-1.15%)

08:18
07/23/19
07/23
08:18
07/23/19
08:18
Recommendations
Under Armour analyst commentary  »

Under Armour's path…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

XLU

Utilities SPDR

$60.25

-0.11 (-0.18%)

08:18
07/23/19
07/23
08:18
07/23/19
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$59.62

-0.3 (-0.50%)

08:18
07/23/19
07/23
08:18
07/23/19
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBPH

Spring Bank Pharmaceuticals

$4.70

-0.45 (-8.74%)

08:18
07/23/19
07/23
08:18
07/23/19
08:18
Hot Stocks
Spring Bank Pharmaceuticals announceds dosing of inarigivir in HBV studies »

Spring Bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$91.57

-0.16 (-0.17%)

08:18
07/23/19
07/23
08:18
07/23/19
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$153.64

-0.29 (-0.19%)

08:17
07/23/19
07/23
08:17
07/23/19
08:17
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$271.60

0.04 (0.01%)

08:17
07/23/19
07/23
08:17
07/23/19
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$297.82

0.65 (0.22%)

08:17
07/23/19
07/23
08:17
07/23/19
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHMA

Chiasma

$6.19

-0.11 (-1.75%)

08:17
07/23/19
07/23
08:17
07/23/19
08:17
Conference/Events
Chiasma to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

XLF

Financial Select Sector

$27.99

0.065 (0.23%)

08:17
07/23/19
07/23
08:17
07/23/19
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$118.79

2.36 (2.03%)

08:16
07/23/19
07/23
08:16
07/23/19
08:16
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

Invesco QQQ Trust

$192.55

1.59 (0.83%)

08:16
07/23/19
07/23
08:16
07/23/19
08:16
Technical Analysis
Invesco QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$COMP

Nasdaq Composite

$0.00

(0.00%)

08:16
07/23/19
07/23
08:16
07/23/19
08:16
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDX

Nasdaq 100 Index

$0.00

(0.00%)

08:16
07/23/19
07/23
08:16
07/23/19
08:16
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFNNY

Infineon

$0.00

(0.00%)

08:14
07/23/19
07/23
08:14
07/23/19
08:14
Initiation
Infineon initiated  »

Infineon initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

MJARF

MJardin Group

$0.00

(0.00%)

08:14
07/23/19
07/23
08:14
07/23/19
08:14
Hot Stocks
MJardin Group receives transfer of license agreement for Nevada facility »

MJardin Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

HK

Halcon Resources

$0.16

-0.0109 (-6.41%)

08:12
07/23/19
07/23
08:12
07/23/19
08:12
Hot Stocks
Halcon Resources announces suspension of trading, commencement of NYSE delisting »

Halcon Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.